Blend Labs (NYSE:BLND - Get Free Report) had its price target lowered by equities research analysts at The Goldman Sachs Group from $5.60 to $4.80 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a "buy" rating on the stock. The Goldman Sachs Group's price objective would suggest a potential upside of 36.40% from the company's previous close.
Other research analysts have also recently issued research reports about the stock. UBS Group reduced their price target on shares of Blend Labs from $4.00 to $3.50 and set a "neutral" rating for the company in a report on Friday, February 28th. Canaccord Genuity Group reiterated a "buy" rating and issued a $5.25 price target on shares of Blend Labs in a report on Monday. Keefe, Bruyette & Woods reduced their target price on shares of Blend Labs from $3.85 to $3.50 and set a "market perform" rating for the company in a report on Monday, March 3rd. Finally, Wells Fargo & Company reduced their target price on shares of Blend Labs from $6.00 to $5.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Blend Labs currently has an average rating of "Moderate Buy" and an average target price of $4.83.
Read Our Latest Stock Analysis on BLND
Blend Labs Stock Performance
NYSE:BLND traded down $0.00 during trading hours on Monday, hitting $3.52. The stock had a trading volume of 2,048,333 shares, compared to its average volume of 3,292,737. Blend Labs has a one year low of $2.08 and a one year high of $5.53. The company has a market cap of $913.75 million, a price-to-earnings ratio of -10.37 and a beta of 1.29. The business's 50 day moving average is $3.33 and its 200-day moving average is $3.88.
Blend Labs (NYSE:BLND - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.02). On average, sell-side analysts anticipate that Blend Labs will post -0.19 EPS for the current fiscal year.
Institutional Trading of Blend Labs
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Barclays PLC grew its stake in shares of Blend Labs by 263.1% in the 3rd quarter. Barclays PLC now owns 407,774 shares of the company's stock worth $1,530,000 after acquiring an additional 295,460 shares in the last quarter. Franklin Resources Inc. bought a new stake in shares of Blend Labs during the third quarter valued at about $2,463,000. Principal Financial Group Inc. increased its position in shares of Blend Labs by 697.6% in the third quarter. Principal Financial Group Inc. now owns 2,733,004 shares of the company's stock worth $10,249,000 after purchasing an additional 2,390,337 shares during the last quarter. JPMorgan Chase & Co. grew its position in Blend Labs by 193.5% during the third quarter. JPMorgan Chase & Co. now owns 1,714,955 shares of the company's stock valued at $6,431,000 after acquiring an additional 1,130,706 shares during the last quarter. Finally, Revolve Wealth Partners LLC bought a new position in Blend Labs during the fourth quarter valued at approximately $132,000. Institutional investors own 52.56% of the company's stock.
Blend Labs Company Profile
(
Get Free Report)
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
